89bio Short Term Debt vs Retained Earnings Analysis

ETNB Stock

USD 8.96 0.20 2.28%

89bio financial indicator trend analysis is way more than just evaluating 89bio Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether 89bio Inc is a good investment. Please check the relationship between 89bio Short Term Debt and its Retained Earnings accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Short Term Debt vs Retained Earnings

Short Term Debt vs Retained Earnings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of 89bio Inc Short Term Debt account and Retained Earnings. At this time, the significance of the direction appears to have very strong relationship.

The correlation between 89bio's Short Term Debt and Retained Earnings is 0.87. Overlapping area represents the amount of variation of Short Term Debt that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of 89bio Inc, assuming nothing else is changed. The correlation between historical values of 89bio's Short Term Debt and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Debt of 89bio Inc are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Short Term Debt i.e., 89bio's Short Term Debt and Retained Earnings go up and down completely randomly.

Correlation Coefficient

0.87

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Short Term Debt

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most indicators from 89bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into 89bio Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At present, 89bio's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 385.4 M, whereas Tax Provision is forecasted to decline to 10,000.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	79K	65K	49K	50.6K
Total Operating Expenses	89.7M	102.2M	151.2M	79.6M

Reconciled Depreciation Total Operating Expenses

89bio fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Net Working Capital
Total Assets		0.86	0.79	1.0	0.75	0.97	-0.94	-0.95	0.64	0.96	0.99	0.65	0.62	1.0	0.88	0.98	-0.03	0.88	0.76	0.99	0.5	1.0	0.97	1.0	0.98	1.0
Other Current Liab	0.86		0.97	0.85	0.8	0.79	-0.79	-0.94	0.85	0.8	0.83	0.62	0.59	0.85	0.91	0.87	0.11	0.89	0.93	0.89	0.72	0.86	0.79	0.86	0.88	0.85
Total Current Liabilities	0.79	0.97		0.78	0.78	0.71	-0.69	-0.93	0.94	0.72	0.75	0.59	0.57	0.79	0.94	0.84	0.12	0.91	0.98	0.85	0.75	0.79	0.71	0.79	0.85	0.78
Total Stockholder Equity	1.0	0.85	0.78		0.77	0.96	-0.95	-0.94	0.62	0.97	0.99	0.68	0.64	1.0	0.87	0.97	-0.08	0.88	0.75	0.99	0.46	1.0	0.96	1.0	0.97	1.0
Net Tangible Assets	0.75	0.8	0.78	0.77		0.56	-0.83	-0.8	0.69	0.82	0.69	0.91	0.91	0.74	0.84	0.68	-0.47	0.91	0.86	0.78	0.21	0.77	0.56	0.75	0.73	0.74
Property Plant And Equipment Net	0.97	0.79	0.71	0.96	0.56		-0.85	-0.9	0.56	0.88	0.98	0.46	0.42	0.97	0.78	0.97	0.15	0.75	0.64	0.95	0.57	0.96	1.0	0.97	0.96	0.97
Net Debt	-0.94	-0.79	-0.69	-0.95	-0.83	-0.85		0.84	-0.47	-1.0	-0.92	-0.79	-0.76	-0.94	-0.8	-0.85	0.26	-0.85	-0.68	-0.91	-0.28	-0.95	-0.85	-0.94	-0.86	-0.94
Retained Earnings	-0.95	-0.94	-0.93	-0.94	-0.8	-0.9	0.84		-0.84	-0.88	-0.93	-0.64	-0.62	-0.95	-0.97	-0.97	-0.02	-0.95	-0.91	-0.98	-0.63	-0.95	-0.9	-0.95	-0.98	-0.94
Accounts Payable	0.64	0.85	0.94	0.62	0.69	0.56	-0.47	-0.84		0.52	0.6	0.49	0.49	0.63	0.87	0.72	0.15	0.83	0.96	0.72	0.73	0.63	0.56	0.64	0.74	0.62
Cash	0.96	0.8	0.72	0.97	0.82	0.88	-1.0	-0.88	0.52		0.94	0.77	0.74	0.96	0.84	0.89	-0.22	0.87	0.71	0.94	0.32	0.97	0.88	0.96	0.89	0.96
Non Current Assets Total	0.99	0.83	0.75	0.99	0.69	0.98	-0.92	-0.93	0.6	0.94		0.62	0.58	1.0	0.83	0.98	0.03	0.83	0.71	0.98	0.52	0.99	0.98	0.99	0.97	1.0
Non Currrent Assets Other	0.65	0.62	0.59	0.68	0.91	0.46	-0.79	-0.64	0.49	0.77	0.62		1.0	0.65	0.66	0.58	-0.44	0.77	0.67	0.66	0.09	0.67	0.46	0.66	0.59	0.66
Other Assets	0.62	0.59	0.57	0.64	0.91	0.42	-0.76	-0.62	0.49	0.74	0.58	1.0		0.62	0.65	0.54	-0.49	0.76	0.67	0.63	0.05	0.64	0.42	0.62	0.56	0.62
Cash And Short Term Investments	1.0	0.85	0.79	1.0	0.74	0.97	-0.94	-0.95	0.63	0.96	1.0	0.65	0.62		0.87	0.98	-0.03	0.87	0.76	0.99	0.5	1.0	0.97	1.0	0.98	1.0
Common Stock Total Equity	0.88	0.91	0.94	0.87	0.84	0.78	-0.8	-0.97	0.87	0.84	0.83	0.66	0.65	0.87		0.89	-0.08	0.99	0.95	0.93	0.58	0.88	0.78	0.88	0.9	0.87
Common Stock Shares Outstanding	0.98	0.87	0.84	0.97	0.68	0.97	-0.85	-0.97	0.72	0.89	0.98	0.58	0.54	0.98	0.89		0.13	0.86	0.79	0.98	0.64	0.97	0.97	0.98	0.99	0.98
Non Current Liabilities Total	-0.03	0.11	0.12	-0.08	-0.47	0.15	0.26	-0.02	0.15	-0.22	0.03	-0.44	-0.49	-0.03	-0.08	0.13		-0.21	-0.03	-0.04	0.75	-0.07	0.15	-0.03	0.04	-0.04
Capital Surpluse	0.88	0.89	0.91	0.88	0.91	0.75	-0.85	-0.95	0.83	0.87	0.83	0.77	0.76	0.87	0.99	0.86	-0.21		0.94	0.92	0.47	0.89	0.75	0.88	0.88	0.87
Other Current Assets	0.76	0.93	0.98	0.75	0.86	0.64	-0.68	-0.91	0.96	0.71	0.71	0.67	0.67	0.76	0.95	0.79	-0.03	0.94		0.83	0.64	0.77	0.64	0.76	0.81	0.75
Other Stockholder Equity	0.99	0.89	0.85	0.99	0.78	0.95	-0.91	-0.98	0.72	0.94	0.98	0.66	0.63	0.99	0.93	0.98	-0.04	0.92	0.83		0.54	0.99	0.95	0.99	0.99	0.99
Total Liab	0.5	0.72	0.75	0.46	0.21	0.57	-0.28	-0.63	0.73	0.32	0.52	0.09	0.05	0.5	0.58	0.64	0.75	0.47	0.64	0.54		0.48	0.57	0.5	0.59	0.49
Net Invested Capital	1.0	0.86	0.79	1.0	0.77	0.96	-0.95	-0.95	0.63	0.97	0.99	0.67	0.64	1.0	0.88	0.97	-0.07	0.89	0.77	0.99	0.48		0.96	1.0	0.98	1.0
Property Plant And Equipment Gross	0.97	0.79	0.71	0.96	0.56	1.0	-0.85	-0.9	0.56	0.88	0.98	0.46	0.42	0.97	0.78	0.97	0.15	0.75	0.64	0.95	0.57	0.96		0.97	0.96	0.97
Total Current Assets	1.0	0.86	0.79	1.0	0.75	0.97	-0.94	-0.95	0.64	0.96	0.99	0.66	0.62	1.0	0.88	0.98	-0.03	0.88	0.76	0.99	0.5	1.0	0.97		0.98	1.0
Capital Stock	0.98	0.88	0.85	0.97	0.73	0.96	-0.86	-0.98	0.74	0.89	0.97	0.59	0.56	0.98	0.9	0.99	0.04	0.88	0.81	0.99	0.59	0.98	0.96	0.98		0.98
Net Working Capital	1.0	0.85	0.78	1.0	0.74	0.97	-0.94	-0.94	0.62	0.96	1.0	0.66	0.62	1.0	0.87	0.98	-0.04	0.87	0.75	0.99	0.49	1.0	0.97	1.0	0.98

Click cells to compare fundamentals

89bio Account Relationship Matchups

89bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	95.6M	211.1M	162.4M	196.8M	596.3M	626.1M
Other Current Liab	4.6M	6.0M	10.2M	11.8M	20.0M	10.2M
Total Current Liabilities	5.6M	8.1M	19.5M	24.6M	29.6M	16.8M
Total Stockholder Equity	89.9M	203.0M	126.0M	151.8M	536.3M	563.1M
Net Tangible Assets	89.9M	203.0M	126.0M	151.8M	174.6M	122.0M
Property Plant And Equipment Net	155K	166K	150K	455K	2.3M	2.5M
Net Debt	(93.4M)	(204.7M)	(131.3M)	(35.2M)	(289.1M)	(274.6M)
Retained Earnings	(73.6M)	(123.1M)	(213.2M)	(315.2M)	(457.4M)	(434.6M)
Accounts Payable	989K	2.1M	6.8M	12.5M	8.6M	6.0M
Cash	93.4M	204.7M	150.7M	55.3M	316.2M	332.0M
Non Current Assets Total	227K	872K	440K	744K	2.7M	2.9M
Non Currrent Assets Other	72K	706K	290K	289K	396K	331.1K
Other Assets	72K	706K	290K	289K	332.4K	302.9K
Cash And Short Term Investments	93.4M	204.7M	150.7M	188.2M	578.9M	607.8M
Common Stock Shares Outstanding	2.3M	16.1M	20.1M	34.8M	71.2M	74.7M
Liabilities And Stockholders Equity	95.6M	211.1M	162.4M	196.8M	596.3M	626.1M
Non Current Liabilities Total	989K	2.1M	16.9M	20.4M	30.4M	17.2M
Other Current Assets	2.0M	5.6M	11.3M	15.8M	14.7M	9.1M
Other Stockholder Equity	163.5M	326.0M	339.2M	467.4M	993.5M	1.0B
Total Liab	5.6M	8.1M	36.5M	45.0M	60.0M	33.5M
Net Invested Capital	89.9M	203.0M	145.4M	171.5M	561.1M	589.2M
Property Plant And Equipment Gross	155K	166K	150K	455K	2.3M	2.5M
Total Current Assets	95.3M	210.2M	162.0M	196.1M	593.5M	623.2M
Accumulated Other Comprehensive Income	(95.6M)	(10K)	(64K)	(350K)	190K	199.5K
Net Working Capital	89.7M	202.1M	142.4M	171.5M	563.9M	592.1M
Property Plant Equipment	155K	166K	150K	92K	105.8K	131.1K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether 89bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 89bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 89bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 89bio Inc Stock:

How To Invest In 89bio

Details

Is 89bio Stock a good investment?

Details

What is 89bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.96)

Return On Assets

(0.41)

Return On Equity

(0.73)

The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

89bio Short Term Debt vs Retained Earnings Analysis

Short Term Debt vs Retained Earnings

Short Term Debt vs Retained Earnings Correlation Analysis

Correlation Coefficient

Short Term Debt

Retained Earnings

89bio fundamental ratios Correlations

89bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

89bio fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity

Cash	- 1.0	Net Debt
Capital Stock	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.98	Retained Earnings
Common Stock Shares Outstanding	- 0.97	Retained Earnings
Common Stock Total Equity	- 0.97	Retained Earnings
Total Current Assets	- 0.95	Retained Earnings